1. Home
  2. HUBB vs WAT Comparison

HUBB vs WAT Comparison

Compare HUBB & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hubbell Inc

HUBB

Hubbell Inc

HOLD

Current Price

$448.65

Market Cap

23.2B

Sector

Technology

ML Signal

HOLD

Logo Waters Corporation

WAT

Waters Corporation

HOLD

Current Price

$384.99

Market Cap

23.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBB
WAT
Founded
1888
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
23.2B
23.0B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
HUBB
WAT
Price
$448.65
$384.99
Analyst Decision
Buy
Buy
Analyst Count
6
15
Target Price
$474.00
$388.67
AVG Volume (30 Days)
483.4K
544.8K
Earning Date
02-03-2026
11-04-2025
Dividend Yield
1.27%
N/A
EPS Growth
15.10
3.82
EPS
15.99
10.88
Revenue
$5,686,200,000.00
$3,105,638,000.00
Revenue This Year
$5.89
$7.96
Revenue Next Year
$7.65
$6.32
P/E Ratio
$28.02
$35.43
Revenue Growth
0.82
6.90
52 Week Low
$299.43
$275.05
52 Week High
$484.26
$423.56

Technical Indicators

Market Signals
Indicator
HUBB
WAT
Relative Strength Index (RSI) 56.01 50.66
Support Level $437.80 $385.08
Resistance Level $449.36 $397.55
Average True Range (ATR) 10.72 9.42
MACD 3.19 -3.19
Stochastic Oscillator 63.13 7.46

Price Performance

Historical Comparison
HUBB
WAT

About HUBB Hubbell Inc

Founded in 1888 by Harvey Hubbell, the eponymous company was the conduit through which the pull-chain lamp socket was originally sold. Hubbell has since grown into an electricity transmission and distribution behemoth, housing more than 75 brands that sell components found on power lines, electrical substations, and within commercial and industrial buildings. The company's primary operations are within the United States, where around 90% of revenue is derived.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: